Technical Analysis for DMPI - DelMar Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.41 -4.65% -0.02
DMPI closed down 4.65 percent on Tuesday, January 15, 2019, on 17 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical DMPI trend table...

Date Alert Name Type % Chg
Jan 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 15 Outside Day Range Expansion 0.00%
Jan 15 Wide Bands Range Expansion 0.00%
Jan 14 Narrow Range Bar Range Contraction -4.65%
Jan 14 Inside Day Range Contraction -4.65%
Jan 14 Wide Bands Range Expansion -4.65%
Jan 11 20 DMA Support Bullish -2.38%
Jan 11 Inside Day Range Contraction -2.38%
Jan 11 Wide Bands Range Expansion -2.38%
Jan 10 New Downtrend Bearish 5.13%

Older signals for DMPI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being evaluated in a Phase II clinical trial for the treatment of refractory GBM. In addition to its clinical development activities in the United States, the Company has obtained certain commercial rights to VAL-083 in China where it is approved as a chemotherapy for the treatment of chronic myelogenous leukemia (CML) and lung cancer. Its drug discovery research focuses on identifying validated clinical and commercial-stage compounds, and establishing a scientific rationale for development in orphan drug indications. VAL-083 is an alkylating agent, which crosses the blood-brain-barrier (BBB).
Is DMPI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.59
52 Week Low 0.31
Average Volume 99,892
200-Day Moving Average 0.6806
50-Day Moving Average 0.4791
20-Day Moving Average 0.3763
10-Day Moving Average 0.402
Average True Range 0.0565
ADX 26.05
+DI 14.6018
-DI 21.0367
Chandelier Exit (Long, 3 ATRs ) 0.3405
Chandelier Exit (Short, 3 ATRs ) 0.4795
Upper Bollinger Band 0.4595
Lower Bollinger Band 0.2931
Percent B (%b) 0.7
BandWidth 44.220037
MACD Line -0.0136
MACD Signal Line -0.0276
MACD Histogram 0.014
Fundamentals Value
Market Cap 8.84 Million
Num Shares 21.6 Million
EPS -0.74
Price-to-Earnings (P/E) Ratio -0.55
Price-to-Sales 0.00
Price-to-Book 77.27
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.52
Resistance 3 (R3) 0.52 0.48 0.50
Resistance 2 (R2) 0.48 0.46 0.48 0.49
Resistance 1 (R1) 0.45 0.44 0.43 0.45 0.49
Pivot Point 0.41 0.41 0.41 0.41 0.41
Support 1 (S1) 0.38 0.39 0.36 0.38 0.33
Support 2 (S2) 0.34 0.37 0.34 0.33
Support 3 (S3) 0.31 0.34 0.32
Support 4 (S4) 0.31